A short practical approach to 24R,25-dihydroxyvitamin D3

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 43-45

  Nicoletti, Daniel ^a   Gregorio, Carlos ^a   Mouriño, Antonio ^a   Maestro, Miguel ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

24R,25 Dihydroxyvitamin D3; 3,3 Sigmatropic rearrangement; Catalytic palladium(0); Wittig Horner approach

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; ACETIC ACID; PALLADIUM; CALCITRIOL; CALCITROIC ACID; HYDROGEN; SECALCIFEROL;

ALLYLIC REARRANGEMENT; ARTICLE; CATALYSIS; DRUG SYNTHESIS; HORNER REACTION; STEREOCHEMISTRY; ANALOGS AND DERIVATIVES; CHEMICAL MODEL; CHEMISTRY; DRUG DESIGN; FRACTURE HEALING; HUMAN; MEDICINAL CHEMISTRY; PROCEDURES; STEREOISOMERISM; SYNTHESIS;

24,25-DIHYDROXYVITAMIN D 3; CALCITRIOL; CATALYSIS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; FRACTURE HEALING; HUMANS; HYDROGEN; MODELS, CHEMICAL; PALLADIUM; STEREOISOMERISM;

EID: 77954758826     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.071     Document Type: Article

References (40)

1. Proceedings of the 12th and 13th Workshop on Vitamin D. J. Steroid Biochem. Mol. Biol. 2007, 103:201-822. 89-90 (2004) 1-633, and the previous 11 volumes in this series.
2. Vitamin D 2005, Academic Press, New York. 2nd ed. D. Feldman, J.W. Pike, F.H. Glorieux (Eds.).
3. Carlberg C., Mouriño A. New vitamin D receptor ligands. Expert Opin. Ther. Patents 2003, 13:761-772.
4. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998, 78:1193-1231.
5. Bouillon R., Okamura W.H., Norman A.W. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 1995, 16:200-257.
6. Henry H.L. Vitamin D. Handbook of Physiology, Section 7: The Endocrine System 2000, 699-718. For a review on actions and biological activity of 24R,25-dihydroxyvitamin D3, see:, Oxford University Press, New Work, NY. H.M. Goodman (Ed.).
7. 3. Mol. Cell. Endocrinol. 2002, 197:1-13.
8. Boyan B.D., Dean D.D., Sylvia V.L., Schwartz Z. Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms. Connect. Tissue Res. 2003, 44:130-135.
9. 3 in growth plate chondrocytes. Biomed. Health Res. 2002, 54:25-35.
10. 3 analogs. Biosci. Biotechnol. Biochem. 2008, 72:246-249.
11. 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 1997, 138:3864-3872.
12. 3 from chick intestine. J. Endocrinol. 2002, 172:211-219.
13. 2 in carp and Atlantic cod enterocytes: characterization of binding and effects on intracellular calcium regulation. J. Cell. Biochem. 2001, 83:171-186.
14. 3 regulates cartilage and bone via autocrine and endocrine mechanisms. Steroids 2001, 66:363-374.
15. 3 in N,N'-dimethylhydrazine-induced rat colon carcinogenesis. Carcinogenesis 2000, 21:173-178.
16. 3. Synthesis and biological activity. Biochemistry 1973, 12:4851-4855.
17. 3. C. R. Seances Acad. Sci. D 1974, 279:529-531.
18. 3. Tetrahedron Lett. 1975, 16:15-18.
19. 3. J. Chem. Soc., Perkin Trans. I 1976, 731-735.
20. 3]. C. R. Seances Acad. Sci. D 1976, 283:857-860.
21. Segal G.M., Torgov I.V. Preparation of 25-hydroxycholesterol and 24,25-dihydroxycholesterol. Bioorganicheskaya Khimiya 1979, 5:1668-1676.
22. 3 usind D-glyceric acid as a chiral synthon. Tetrahedron Lett. 1980, 21:5027-5028.
23. Ishiguro M, Koizumi N., Yasuda M., Ikekawa N. Stereoselective introduction of hydroxy-groups into the 24,25-, and 26-positions of the cholesterol side chain. J. Chem. Soc., Chem. Commun. 1981, 115-117.
24. 3 by asymmetric synthesis. J. Chem. Soc., Perkin Trans. I 1983, 1401-1410.
25. Seki M., Rubio-Lightbourn J., Morisaki M., Ikekawa N. Synthesis of active forms of vitamin D. IV. Synthesis of 24,25- and 25,26-dihydroxycholesterols. Chem. Pharm. Bull. 1973, 21:2783-2785.
26. Fürst A., Labler L., Meier W. Synthesis of 24R,25-dihydroxycholecalciferol. A stereoselective synthesis of 24R,25-dihydroxycholesterol. Vitamin D, Chemical, Biochemical and Clinical Update 1985, 733-738. Walter de Gruyter, Berlin/New York. A.W. Norman, K. Schaefer, H.-G. Grigoleit, D.V. Herrath (Eds.).
27. 3 northern portion from (S)-3- hydroxy-2,2-dimethylcyclohexane-1-one. Remote asymmetric induction in an acid-catalysed conjugate addition. Tetrahedron Lett. 1998, 39:885-888.
28. Odrzywolska M., Chodynski M., Zorgdrager J., Van de Velde J.-P., Kütner A. Diastereoselective synthesis, binding affinity for vitamin D receptor, and chiral stationary phase chromatography of hydroxy analogs of 1,25-dihydroxycholecalciferol and 25-dihydroxycholecalciferol. Chirality 1999, 11:701-706.
29. 3 metabolites: a practical approach. Chem. Eur. J. 2002, 8:2747-2752.
30. The identity of the synthetized 24R,25-dihydroxyvitamin D3 (1) was established by comparison of its Rf, 1H and 13C-NMR data with a reference sample from our laboratory.
31. Cornella I., Suárez R.M., Mouriño A., Pérez-Sestelo J., Sarandeses L.A. Stereoselective convergent synthesis of 24-substituted metabolites and analogues of vitamin D. J. Steroid Biochem. Mol. Biol. 2004, 89-90:19-23.
32. 3. Tetrahedron Lett. 2007, 48:2939-2942.
33. Baggiolini E.G., Iacobelli J.A., Hennessy B.M., Uskokovic M.R. Stereoselective total synthesis of 1α, 25-dihydroxycholecalciferol. J. Am. Chem. Soc. 1982, 104:2945-2948.
34. 3. J. Chem. Soc., Perkin Trans. 1978, 1:590-595.
35. Fernández B., Martínez J.A., Granja J.R., Castedo L., Mouriño A. Synthesis of hydrindan derivatives related to vitamin D. J. Org. Chem. 1992, 57:3173-3178.
36. 2 (1α,25-dihydroxyergocalciferol) and C-24 analogs. J. Org. Chem. 1997, 62:6344-6352.
37. Grieco P., Takigawa T., Bongers S.L., Tanaka H. Complete transfer of chirality in the [3,3]-sigmatropic rearrangement of allylic acetates catalyzed by palladium(II). Application to stereocontrolled syntheses of prostaglandins possessing either the C-15(S) or C-15(R) configuration. J. Am. Chem. Soc. 1980, 102:7587-7588.
38. Takatsuto S., Ishiguro M., Ikekawa N. Chirality transfer in the cholesterol side chain; synthesis of (24R)- and (24S)-24 cholesterol. J. Chem. Soc., Chem. Commun. 1982, 258-260.
39. Kawatsura M., Uozumi Y., Ogasawara M., Hayashi T. Palladium-catalyzed asymetric reduction of racemic allylic esters with formic acid: effects of phosphine ligands on isomerization of π-allylpalladium intermediates and enantioselectivity. Tetrahedron 2000, 56:2247-2257.
40. Trost B.M., Van Vranken D.L. Asymetric transition metal-catalyzed allylic alkylations. Chem. Rev. 1996, 96:395-422.